1. Home
  2. ATER vs INAB Comparison

ATER vs INAB Comparison

Compare ATER & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aterian Inc.

ATER

Aterian Inc.

HOLD

Current Price

$1.27

Market Cap

14.3M

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.41

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATER
INAB
Founded
2014
2016
Country
United States
United States
Employees
74
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3M
13.7M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
ATER
INAB
Price
$1.27
$1.41
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
146.5K
36.5K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
55.77
N/A
EPS
N/A
N/A
Revenue
$68,975,000.00
N/A
Revenue This Year
$16.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$1.17
52 Week High
$1.87
$2.73

Technical Indicators

Market Signals
Indicator
ATER
INAB
Relative Strength Index (RSI) 52.67 46.20
Support Level $0.59 $1.34
Resistance Level $1.32 $1.53
Average True Range (ATR) 0.10 0.07
MACD -0.01 0.00
Stochastic Oscillator 30.00 52.36

Price Performance

Historical Comparison
ATER
INAB

About ATER Aterian Inc.

Aterian Inc is a consumer products company that operates through online retail channels, including Amazon, Walmart, Target, as well as its own direct-to-consumer websites. The company develops and manages a portfolio of owned brands, which are either internally incubated or acquired, offering products across multiple categories such as home and kitchen appliances, kitchenware, air quality appliances, health and beauty products, and essential oils. Its primary brands include Squatty Potty, HomeLabs, Mueller Living, PurSteam, Healing Solutions, and Photo Paper Direct. The company generates revenue mainly through the online sale of its consumer products, with substantially all sales derived from the Amazon U.S. marketplace.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

Share on Social Networks: